Towards precision medicine: CCL2, another brick in the wall?

Eur Respir J. 2019 Mar 7;53(3):1802327. doi: 10.1183/13993003.02327-2018. Print 2019 Mar.

Authors

Andriani Charpidou¹, Elias Kotteas¹, Mina Gaga²

Affiliations

¹ Oncology Unit, 3rd Internal Medicine Dept, Medical School, National Kapodistrian University of Athens, Athens Chest Hospital Sotiria, Athens, Greece.
² 7th Respiratory Medicine Dept, Athens Chest Hospital Sotiria, Athens, Greece.

PMID: 30846448
DOI: 10.1183/13993003.02327-2018

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Chemokine CCL2
Humans
Indoles
Lung Neoplasms*
Precision Medicine
Quinolines*

Substances

CCL2 protein, human
Chemokine CCL2
Indoles
Quinolines
anlotinib